Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer

The development of targeted therapies increases treatment options for metastatic castration resistant prostate cancer (mCRPC) patients. There is a need for strong predictive and prognostic signatures to guide physicians in treating mCRPC patients. In this review we unravel the possible actionability...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cells
Main Authors: Devlies, Wout, Eckstein, Markus, Cimadamore, Alessia, Devos, Gaëtan, Moris, Lisa, Van den Broeck, Thomas, Montironi, Rodolfo, Joniau, Steven, Claessens, Frank, Gevaert, Thomas
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7698403/
https://ncbi.nlm.nih.gov/pubmed/33212909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9112494
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki